-
Precision Medicine in Type 2 Diabetes—Using Individualized Prediction Models to Optimize Selection of Treatment
John M. Dennis, PhD, previews his presentation “Precision Medicine in Type 2 Diabetes—Using Individualized Prediction Models to Optimize Selection of Treatment,” which begins at 8:30 a.m. CT Sunday, June 14.
-
Built Environment and Disadvantaged Communities
Tiffany L. Gary-Webb, PhD, MHS, previews her presentation “Built Environment and Disadvantaged Communities,” which begins at 12:40 p.m. CT Monday, June 15.
-
When Should You Order Coronary Artery Calcium (CAC) Scans?
Matthew J. Budoff, MD, Professor of Medicine, University of California, Los Angeles, School of Medicine, previews his presentation “When Should You Order Coronary Artery Calcium (CAC) Scans?,” which begins at 12:00 CT Friday, June 12.
-
Histologic Analysis of Prohormone Processing
Teresa Rodriguez-Calvo, DVM, PhD, previews her presentation “Histologic Analysis of Prohormone Processing,” which begins at 3:15 p.m. CT Saturday, June 13.
-
Beta Cells Releasing Information
Anath Shalev, MD, previews her presentation “Beta Cells Releasing Information,” which begins at 3:15 p.m. CT Monday, June 15.
-
Use of AI to Screen for Complications
Arianna Dagliati, PhD, previews her presentation “Use of AI to Screen for Complications,” which begins at 3:35 p.m. CT Monday, June 15.
-
Effects of Diabetes on Menopause Onset and Symptoms and Osteoporosis
Sarit Polsky, MD, MPH, previews her presentation “Effects of Diabetes on Menopause Onset and Symptoms and Osteoporosis,” which begins at 5:10 p.m. CT Sunday, June 14.
-
A New Era—Leveraging RDNs in Medication Management in Reducing Therapeutic Inertia
Gretchen Benson, RDN, CDCES, discussed how a team-based approach featuring an expanded role for registered dietitian nutritionists (RDN) can help patients with type 2 diabetes, hypertension, and hyperlipidemia achieve better outcomes. She highlighted results from several studies demonstrating the benefits of expanding the role of RDNs in initiating/titrating medications.
-
Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4
Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13.
-
Educating Patients to Succeed with Advanced Pump Therapy
Laurel H. Messer, PhD, RN, previews her session “Educating Patients to Succeed with Advanced Pump Therapy,” which will begin at 9:00 a.m. CT Monday, June 15.